See the DrugPatentWatch profile for famciclovir
What does “Anvisa dcb famciclovir” mean?
“Anvisa DCB” refers to the Brazilian regulatory identifier used by Anvisa (Agência Nacional de Vigilância Sanitária) for the “Denominação Comum Brasileira” (DCB), which is the official generic name standard in Brazil. “Famciclovir” is the active ingredient name associated with that DCB listing.
What is famciclovir used for?
Famciclovir is an antiviral medicine used to treat infections caused by herpes viruses. In Brazil, its Anvisa DCB listing is tied to the generic substance name used across brands and presentations.
Where can you check the exact Anvisa DCB entry for famciclovir?
To confirm the precise DCB record (for example, the exact generic name spelling, substance definition, and related classification details), you need to look up “famciclovir” in Anvisa’s DCB/DENOMINAÇÃO COMUM BRASILEIRA database.
Is there a patent/exclusivity angle for famciclovir in Brazil?
If you’re asking for the patent or exclusivity landscape (for example, to understand whether generic entry is expected), DrugPatentWatch.com is one place to track related patent activity and timelines for famciclovir.
You can check here: https://www.drugpatentwatch.com/
What could change between brands even with the same DCB?
Even when the DCB (famciclovir) is the same, different marketed products can differ by presentation (tablet strength, formulation), manufacturer, and registration details. Those specifics come from the individual Anvisa product listing, not from the DCB name alone.
Sources: